RetinalGenix Technologies RTGN
OTC RTGN
$3.99 +0.00 (+0.00%)
At close: Sep 25, 2026 · 4:00 PM EDT

RetinalGenix Technologies (RTGN) Selling, General & Administrative (2021 - 2026)

Updated

RetinalGenix Technologies (RTGN) posted Selling, General & Administrative of $212,254 for Q2 2026, down 44.7% from $383,729 a year earlier and down 19.0% from the prior quarter.

Analysis

RetinalGenix Technologies (RTGN) Selling, General & Administrative (2021 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Selling, General & Administrative at RetinalGenix Technologies was $1.05 million, down 22.8% year-over-year; for FY2025, it came in at $1.3 million, down 2.5% from FY2024.

  • Annual Selling, General & Administrative shows a five-year compound annual growth rate of -1.8% (FY2020 to FY2025).
  • In prior years, RetinalGenix Technologies' Selling, General & Administrative was $1.33 million in FY2024 (+48.4%), $898,658 in FY2023 (+11.3%), $807,406 in FY2022 (-28.0%) and $1.12 million in FY2021 (-21.4%).
  • The Q2 2026 figure stands as the lowest quarterly Selling, General & Administrative since Q3 2023.
  • On a year-over-year basis, Selling, General & Administrative has declined in each of the last three quarters, with an average decline of 3.7% over the last eight quarters.
  • The strongest year-over-year quarter for Selling, General & Administrative in the past five years was Q2 2024, with growth of 207.0%; the weakest was Q1 2022, with a decline of 56.1%.
  • According to Business Quant data, Selling, General & Administrative for the three prior quarters was $262,149 (Q1 2026), $305,871 (Q4 2025) and $270,153 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Thermo Fisher Scientific 250.84 Bn 229.99 Bn 4.88 Bn 2.33 Bn
2 Abbott Laboratories 174.73 Bn 145.82 Bn 7.27 Bn 4.03 Bn
3 Danaher 159.85 Bn 143.67 Bn 3.61 Bn 2.07 Bn
4 Intuitive Surgical 146.79 Bn 126.35 Bn 1.96 Bn 617.90 Mn
5 Medtronic 114.54 Bn 80.41 Bn 6.34 Bn 3.20 Bn
6 Stryker 105.67 Bn 91.79 Bn 4.50 Bn 2.23 Bn
7 Boston Scientific 63.93 Bn 58.94 Bn 3.85 Bn 1.80 Bn
8 Becton Dickinson 50.12 Bn 47.27 Bn 2.32 Bn 1.26 Bn
9 Edwards Lifesciences 50.06 Bn 34.17 Bn 1.35 Bn 561.20 Mn
10 RetinalGenix Technologies 75.19 Mn 75.14 Mn - 212,254.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 212,254.00
Mar 31, 2026 262,149.00
Dec 31, 2025 305,871.00
Sep 30, 2025 270,153.00
Jun 30, 2025 383,729.00
Mar 31, 2025 341,203.00
Dec 31, 2024 392,109.00
Sep 30, 2024 244,098.00
Jun 30, 2024 368,738.00
Mar 31, 2024 328,985.00
Dec 31, 2023 408,273.00
Sep 30, 2023 167,046.00
Jun 30, 2023 120,097.00
Mar 31, 2023 203,242.00
Dec 31, 2022 277,678.00
Sep 30, 2022 201,148.00
Jun 30, 2022 167,385.00
Mar 31, 2022 161,195.00
Dec 31, 2021 171,004.00
Sep 30, 2021 293,893.00
API Access

RetinalGenix Technologies Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=RTGN&period=max&api_key=YOUR_API_KEY